PSMB9 and neoplasm: In vitro study suggested that LMP2-specific CTLs induced by EBV-LMP2 recombinant adenovirus vaccine elicit cytotoxicity effect on tumour cells via the perforin/ granzyme and Fas/FasL pathways (Ge et al., 2020).